Anti-SARS-CoV-2 Immunoglobulin G Antibody Titers in Contemporary Lots of Intravenous Immunoglobulin and Fresh Frozen Plasma Compared With COVID-19 Convalescent Plasma.
Given declining coronavirus disease 2019 convalescent plasma (CCP) collection and increasing scarcity, we compared anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) antibody titers between CCP, intravenous immunoglobulin, and fresh frozen plasma. Herein, we report comparative anti-SARS-CoV-2 IgG antibody titers between 5 lots of each blood product, using the DiaSorin Liaison SARS-CoV-2 TrimericS IgG assay.
期刊介绍:
Clinical Infectious Diseases (CID) is dedicated to publishing original research, reviews, guidelines, and perspectives with the potential to reshape clinical practice, providing clinicians with valuable insights for patient care. CID comprehensively addresses the clinical presentation, diagnosis, treatment, and prevention of a wide spectrum of infectious diseases. The journal places a high priority on the assessment of current and innovative treatments, microbiology, immunology, and policies, ensuring relevance to patient care in its commitment to advancing the field of infectious diseases.